U.S. flag

An official website of the United States government

NIH: Fogarty International Center NIH: Fogarty International Center
Advancing Science for Global Health
Advancing Science for Global Health
Home > Funding > Funding Newsletter for Global Health Researchers > NIH Global Health Funding News - Week of January 14, 2019 Print

COVID-19: COVID-19 public health information from the US CDC | COVID-19 research information from the US NIH | Español | COVID-19 resources for global health researchers

NIH Global Health Funding News - Week of January 14, 2019

On behalf of the Fogarty International Center at the U.S. National Institutes of Health (NIH), the following funding opportunities, notices and announcements may be of interest to those working in the field of global health research. Updates are typically distributed once a week.

Funding Opportunities

NIH funding opportunities focusing on global health and foreign collaboration, and related news.

  • Notice of Intent to Publish Funding Opportunity Announcements for Phase 2 of the U.S.-South Africa Program for Collaborative Biomedical Research (R01 and U01, Clinical Trial Optional) (NOT-AI-19-032)
    The intent of the U.S.-South Africa Program for Collaborative Biomedical Research is to foster, stimulate, and/or expand basic, translational, behavioral and applied research that will advance scientific discovery and engage U.S. and South African researchers working collaboratively in the areas of HIV/AIDS, HIV/AIDS-associated malignancies, and other infectious diseases. These funding announcements are expected to be published in March 2019 with an expected application due date in July 2019.

  • Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed) (PAR-19-149) and (R21 Clinical Trial Optional) (PAR-19-150)
    Application Receipt/Submission Date(s): Standard dates apply
    Note: This announcement aims to support first steps toward delivery of new capabilities to meet evolving requirements for technologies and methods relevant to the advance of research and/or medical care in pre-clinical, clinical and non-clinical settings, domestic or foreign, for conditions and diseases within the missions of participating NIH Institutes and Centers.

  • Notice of Letter of Intent Guidance for PAR-19-098 Emerging Global Leader Award (K43; Independent Clinical Trial Not Allowed) and PAR-19-051 Emerging Global Leader Award (K43; Independent Clinical Trial Required) (NOT-TW-19-001)
    More about Fogarty’s Emerging Global Leader Award.

NIH funding opportunities for which foreign organizations, foreign components of U.S. organizations and/or other foreign components may apply.

NIH funding opportunities for which United States small business concerns (SBCs) may collaborate with a foreign business entity.

Funding News

NIH funding news that may be relevant to global health researchers.

  • Removal of the Requirement for Institutional Review Board Review of NIH Grant Applications and Contract Proposals Related to Research (NOT-OD-19-055)
  • NIH Policy for Review and Resubmission of New Investigator R01 Applications (NOT-OD-19-053)
  • Notice of Clarification Regarding Harassment and Discrimination Protections in NIH Training Applications (NOT-OD-19-056)
  • Request for Information (RFI): Inviting Comments on the NIDA Strategic plan for Research at the Intersection of HIV/AIDS and Substance Use, Misuse and Addiction (NOT-DA-19-015)
  • Notice of Information: Updates and clarifications of several components of the [Antimicrobial Resistance Rapid, Point-of-Need Diagnostic Test] Challenge competition posted within the Federal Register (NOT-OD-19-046)
  • Notice of Special Interest in Understanding Factors in Infancy and Early Childhood (Birth to 24 months) That Influence Obesity Development (NOT-DK-19-007)
  • Notice of NIMHD's Interest in Research on Disability in Health Disparity Populations (NOT-MD-19-007)
  • Notice of Participation of the National Institute on Minority Health and Health Disparities (NIMHD) in Research on Current Topics in Alzheimers Disease and its Related Dementias PAR-19-070, (R01 Clinical Trial Optional) (NOT-MD-19-016) and PAR-19-071 (R21 Clinical Trial Not Allowed) (NOT-MD-19-017)
  • AHRQ Announces Change in Grant Recipient Purchasing of Identifiable CMS Data, effective FY2019 (NOT-HS-19-007)
  • Register to Attend the NIH Regional Seminar on Program Funding and Grants Administration Baltimore, MD May 2019 (NOT-OD-19-058)

Upcoming Deadlines